http://ift.tt/eA8V8J The IL-1? inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by reducing inflammation, according to late-breaking results.
from Latest Science News -- ScienceDaily http://ift.tt/2wT04cW
via IFTTT
No comments:
Post a Comment